Optimi Health Provides Progress Report On Year Of Commercialization
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise VANCOUVER, British Columbia, Sept. 01, 2022 - Optimi Health Corp. (CSE:OPTI)(OTCQX:OPTHF)(FRA:8BN)("Optimi" or the "Company"), a Canadian-based company licensed by Health Canada to produce ... [Read]
Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global
VANCOUVER, British Columbia, Sept. 07, 2022 — Optimi Health Corp. (CSE:OPTI)(OTCQX:OPTHF)(FRA:8BN)("Optimi" or the "Company"), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushroom products for transformational human ... [Read]